Renewing the Debate on Who has Oversight on Lab Tests, FDA Proposes New Rule

Citing a continued dramatic growth in the use of laboratory-developed tests (LDT) over the past two decades, the FDA Friday announced a proposed rule that would bring the tests under the agency’s purview, trying a new route to put to rest the decades-long debate over who should provide oversight.
Source: Drug Industry Daily